Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-061426

Chief Executive Officer sold 65,000 shares at an average $65.77 ($4,274,982)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-20 Sale : show line 1 in the form −15,000 $66.23 $993,450 3,329,022 D
2021-10-22 Sale : show line 2 in the form −44,170 $65.57 $2,896,227 3,284,852 D
2021-10-22 Sale : show line 3 in the form −5,830 $66.09 $385,305 3,279,022 D
Open-market sales · 65,000 sh · avg $65.77 · $4,274,982
Loading xslF345X03/doc4.xml…